Clinical Trial Update: Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 1/2 trial evaluating nab-paclitaxel in combination with gemcitabine in fragile patients with advanced pancreatic c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: PH Research, S.L. | Conditions: Advanced Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED